Cargando…

Targeting chemokines for acute lymphoblastic leukemia therapy

Acute lymphoblastic leukemia (ALL) is a hematological malignancy characterized by the malignant clonal expansion of lymphoid hematopoietic precursors. It is regulated by various signaling molecules such as cytokines and adhesion molecules in its microenvironment. Chemokines are chemotactic cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Zixi, Wei, Zimeng, Xie, Tian, Fu, Lin, Sun, Jiaxing, Zhou, Fuling, Jamal, Muhammad, Zhang, Qiuping, Shao, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981899/ https://www.ncbi.nlm.nih.gov/pubmed/33743810 http://dx.doi.org/10.1186/s13045-021-01060-y

Ejemplares similares

Immune dysregulation and system pathology in COVID-19
por: Jamal, Muhammad, et al.
Publicado: (2021)

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
por: Shi, Jiangzhou, et al.
Publicado: (2021)

Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
por: Wu, Yingjie, et al.
Publicado: (2020)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021)

Imbalance of Chemokines and Cytokines in the Bone Marrow Microenvironment of Children with B-Cell Acute Lymphoblastic Leukemia
por: Magalhães-Gama, Fábio, et al.
Publicado: (2021)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
por: Ghelli Luserna Di Rorà, Andrea, et al.
Publicado: (2018)

Pediatric Acute Lymphoblastic Leukemia Emerging Therapies—From Pathway to Target
por: Ivanov, Anca Viorica, et al.
Publicado: (2023)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

Targeting Telomere Biology in Acute Lymphoblastic Leukemia
por: Karow, Axel, et al.
Publicado: (2021)

WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
por: Hladnik,1, Lindsay, et al.
Publicado: (2016)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells
por: Fregona, Vincent, et al.
Publicado: (2021)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
por: Pikman, Yana, et al.
Publicado: (2021)

MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies
por: Li, Qilong, et al.
Publicado: (2021)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
por: Dussiau, Charles, et al.
Publicado: (2015)

Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia
por: Dobrovinskaya, Oxana, et al.
Publicado: (2016)

Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022)

Recent updates for antibody therapy for acute lymphoblastic leukemia
por: Li, Le, et al.
Publicado: (2020)

WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia
por: Hu, Juncheng, et al.
Publicado: (2020)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
por: Zheng, Ruyue, et al.
Publicado: (2020)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
por: Zhang, Cheng, et al.
Publicado: (2015)

Targeted genome editing in acute lymphoblastic leukemia: a review
por: Montaño, Adrián, et al.
Publicado: (2018)

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
por: Minieri, Valentina, et al.
Publicado: (2018)

Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
por: Sanchez, Vanessa Edna, et al.
Publicado: (2019)

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia
por: Porazzi, Patrizia, et al.
Publicado: (2021)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia
por: Huang, Fang-Liang, et al.
Publicado: (2021)

A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia
por: Shikdar, Sufana, et al.
Publicado: (2022)

Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2021)

Autoimmune Ataxia During Maintenance Therapy for Acute Lymphoblastic Leukemia
por: Voeller, Julie, et al.
Publicado: (2018)

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors
por: Kızılocak, Hande, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kjs79glk1879h1d2ovcnv9st32